Cliical Trials: Reconsenting & Corrective Measures

Reconsenting Subjects After Protocol Deviations: When, Why and How Reconsenting Subjects After Protocol Deviations: When, Why and How The integrity of clinical trial research is paramount, and protocol deviations can jeopardize this integrity. Reconsenting subjects after such deviations is a critical process that clinical operations, regulatory affairs, and medical affairs professionals must navigate carefully. This…

Read More “Reconsenting Subjects After Protocol Deviations: When, Why and How” »

IRB/IEC Expectations for Reconsent Following Major Deviations IRB/IEC Expectations for Reconsent Following Major Deviations In clinical research, maintaining compliance with ethical and regulatory standards is paramount. The role of Institutional Review Boards (IRB) and Independent Ethics Committees (IEC) is critical in ensuring participant safety and informed consent throughout the clinical trial process. This article provides…

Read More “IRB/IEC Expectations for Reconsent Following Major Deviations” »

Documenting Reconsent Discussions and Updated Informed Consent Forms Documenting Reconsent Discussions and Updated Informed Consent Forms In the domain of clinical trials, particularly those regulated by the FDA, EMA, and MHRA, maintaining robust ethical standards is paramount. One of the critical components of adhering to these ethical standards is the process of informed consent. This…

Read More “Documenting Reconsent Discussions and Updated Informed Consent Forms” »

Corrective Measures for Eligibility, Dosing and Visit Deviations Corrective Measures for Eligibility, Dosing and Visit Deviations In clinical trials, maintaining compliance with the protocol is crucial to ensuring the validity of the study. Protocol deviations, such as eligibility, dosing, and visit deviations, necessitate corrective measures for the integrity of the clinical trial. This comprehensive guide…

Read More “Corrective Measures for Eligibility, Dosing and Visit Deviations” »

Reconsent Strategies in DCT, eConsent and Remote Visit Models In the evolving landscape of clinical trials, particularly in fields such as schizophrenia clinical trials, reconsent strategies are becoming increasingly critical. This guide aims to provide clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU with a comprehensive walkthrough on implementing…

Read More “Reconsent Strategies in DCT, eConsent and Remote Visit Models” »

Aligning Reconsent Requirements Across Global Regulatory Regions Aligning Reconsent Requirements Across Global Regulatory Regions In the evolving landscape of clinical research, ensuring alignment in reconsent requirements across different regulatory bodies is critical for compliance and the integrity of clinical trials. As professionals engaged in clinical operations, regulatory affairs, and medical affairs, understanding how variations exist…

Read More “Aligning Reconsent Requirements Across Global Regulatory Regions” »

Balancing Subject Burden With Ethical and Regulatory Obligations Balancing Subject Burden With Ethical and Regulatory Obligations Clinical trials are paramount for advancing medical knowledge and therapeutic development. However, they also present unique challenges in maintaining ethical standards while ensuring stringent regulatory compliance. A particularly sensitive area is the management of patient enrollment in clinical trials,…

Read More “Balancing Subject Burden With Ethical and Regulatory Obligations” »

Case Studies: Reconsent Decisions That Protected Subjects and Data Integrity Case Studies: Reconsent Decisions That Protected Subjects and Data Integrity The integrity of clinical trials hinges not only on robust methodologies but also on the ethical treatment of participants. In the domain of clinical research, there are instances where trial amendments or study protocol modifications…

Read More “Case Studies: Reconsent Decisions That Protected Subjects and Data Integrity” »

Training Investigators on When Reconsent Is Mandated vs Optional Training Investigators on When Reconsent Is Mandated vs Optional Clinical trials are governed by stringent regulations and ethical standards, requiring careful consideration of participant rights during the entire study duration. Reconsenting participants is a crucial aspect of maintaining adherence to ethical standards and regulatory requirements. This…

Read More “Training Investigators on When Reconsent Is Mandated vs Optional” »